Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Wonsang Yu CEO | KRX SM Exchange | KR7000221002 ISIN |
South Korea Country | 253 Employees | - Last Dividend | 30 Mar 2021 Last Split | - IPO Date |